Inventor · disambiguated record
Andrea Fanjul
Also filed as: FANJUL ANDREA · FANJUL ANDREA N
8 granted patents·3 pending applications·111 citations·filing 2000–2025
87Inventor score
Files withORTHO MCNEIL PHARM INC3INCYTE SAN DIEGO2PFAHL MAGNUS2TAKEDA PHARMACEUTICALS CO2MAXIA PHARMACEUTICALS INC1
Top patents by PatentIndex Score
11 records- 0190US6765013B2Thiazolidinedione derivatives for the treatment of diabetes and other diseasesINCYTE SAN DIEGO·Filed 2002·Granted Jul 20, 2004·37 cites·32 claims
- 0289US6515003B1Heterocyclic derivatives for the treatment of diabetes and other diseasesMAXIA PHARMACEUTICALS INC·Filed 2000·Granted Feb 4, 2003·42 cites·23 claims
- 0380US11746155B2Cannabinoid receptor type 1 (CB1) binding proteins and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Sep 5, 2023·1 cites·25 claims
- 0480US7226940B2Substituted heterocycles for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2005·Granted Jun 5, 2007·3 cites·20 claims
- 0578US7153875B2Heterocyclic derivatives for the treatment of cancer and other proliferative diseasesINCYTE SAN DIEGO·Filed 2002·Granted Dec 26, 2006·13 cites·9 claims
- 0677US7071218B2N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseasesORTHO MCNEIL PHARM INC·Filed 2002·Granted Jul 4, 2006·10 cites·45 claims
- 0774US6974826B2Imidazolidinedione derivatives for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2004·Granted Dec 13, 2005·5 cites·32 claims
- 0860US2025250341A1Cannabinoid receptor type 1 (cb1) binding proteins and uses thereofTAKEDA PHARMACEUTICAL·Filed 2025·Application pending·0 cites
- 0957US12202901B2Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid molecules thereof and methods of use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jan 21, 2025·0 cites·18 claims
- 1050US2006160796A1N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseasesPFAHL MAGNUS·Filed 2006·Application pending·0 cites
- 1147US2005209286A1RXR activating moleculesPFAHL MAGNUS·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrea Fanjul files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →